Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

1 st -Line Treatment with R-CHOP-14 or R-CHOP-21 in Patients with High-Grade Non-Hodgkin’s Lymphoma Is Similarly Effective: Data from the German Prospective TLN Registry

Wolfgang Knauf, MD PhD, Wolfgang Abenhardt, MD, Johannes Mohm, MD, Jacqueline Rauh, MD, Renate Grugel, Johanna Harde, Martina Jänicke, PhD, Norbert Marschner, MD

Blood (2014) 124 (21): 4406.

https://doi.org/10.1182/blood.V124.21.4406.4406

Published: 2014

Journal Articles

Response To 1 st -Line Treatment With BR Or FCR In Patients With Chronic Lymphocytic Leukaemia: First Outcome Data From The German Prospective TLN Registry

Wolfgang Knauf, MD, Wolfgang Abenhardt, MD, Erik Engel, Renate Grugel, Johanna Harde, Norbert Marschner, MD

Blood (2013) 122 (21): 4181.

https://doi.org/10.1182/blood.V122.21.4181.4181

Published: 2013

Journal Articles

Response To 1 st -Line Treatment With BR Or R-CHOP In Patients With Indolent Non-Hodgkin’s Lymphoma: First Outcome Data From The German Prospective TLN Registry

Wolfgang Knauf, MD, Wolfgang Abenhardt, MD, Richard Hansen, MD, Renate Grugel, Johanna Harde, Norbert Marschner, MD

Blood (2013) 122 (21): 3036.

https://doi.org/10.1182/blood.V122.21.3036.3036

Published: 2013

Journal Articles

Bendamustine Replaces Chlorambucil As “Standard of Care” in the Treatment of Elderly Patients with Chronic Lymphocytic Leukemia in German Hematology Outpatient Centres

Wolfgang Ulrich Knauf, MD, Wolfgang Abenhardt, MD, Arnd Nusch, MD, Renate Grugel, Norbert Marschner, MD

Blood (2012) 120 (21): 4605.

https://doi.org/10.1182/blood.V120.21.4605.4605

Published: 2012

Journal Articles

Bendamustine-Rituximab (BR) Replaces R-CHOP As “Standard of Care” in the Treatment of Indolent Non-Hodgkin Lymphoma in German Hematology Outpatient Centres

Wolfgang Ulrich Knauf, MD, Wolfgang Abenhardt, MD, Arnd Nusch, MD, Renate Grugel, Norbert Marschner, MD

Blood (2012) 120 (21): 3666.

https://doi.org/10.1182/blood.V120.21.3666.3666

Published: 2012

NARROW

1 st -Line Treatment with R-CHOP-14 or R-CHOP-21 in Patients with High-Grade Non-Hodgkin’s Lymphoma Is Similarly Effective: Data from the German Prospective TLN Registry

Response To 1 st -Line Treatment With BR Or FCR In Patients With Chronic Lymphocytic Leukaemia: First Outcome Data From The German Prospective TLN Registry

Response To 1 st -Line Treatment With BR Or R-CHOP In Patients With Indolent Non-Hodgkin’s Lymphoma: First Outcome Data From The German Prospective TLN Registry

Bendamustine Replaces Chlorambucil As “Standard of Care” in the Treatment of Elderly Patients with Chronic Lymphocytic Leukemia in German Hematology Outpatient Centres

Bendamustine-Rituximab (BR) Replaces R-CHOP As “Standard of Care” in the Treatment of Indolent Non-Hodgkin Lymphoma in German Hematology Outpatient Centres

Email alerts

ASH Publications

American Society of Hematology

1 st -Line Treatment with R-CHOP-14 or R-CHOP-21 in Patients with High-Grade Non-Hodgkin’s Lymphoma Is Similarly Effective: Data from the German Prospective TLN Registry

Response To 1 st -Line Treatment With BR Or FCR In Patients With Chronic Lymphocytic Leukaemia: First Outcome Data From The German Prospective TLN Registry

Response To 1 st -Line Treatment With BR Or R-CHOP In Patients With Indolent Non-Hodgkin’s Lymphoma: First Outcome Data From The German Prospective TLN Registry

Bendamustine Replaces Chlorambucil As “Standard of Care” in the Treatment of Elderly Patients with Chronic Lymphocytic Leukemia in German Hematology Outpatient Centres

Bendamustine-Rituximab (BR) Replaces R-CHOP As “Standard of Care” in the Treatment of Indolent Non-Hodgkin Lymphoma in German Hematology Outpatient Centres

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only